Skip to content

Impact of Respiratory Muscle Unloading on Respiratory Muscle Endurance

Impact of Respiratory Muscle Unloading on Respiratory Muscle Endurance

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00415896
Enrollment
10
Registered
2006-12-25
Start date
2006-12-31
Completion date
2007-06-30
Last updated
2006-12-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Respiratory Failure

Keywords

weaning, work of breathing, spontaneous breathing trial, rapid shallow breathing

Brief summary

This study investigates how different degrees of muscular unloading during mechanical ventilation impact endurance of succeeding spontaneous breathing trials

Detailed description

Liberation from mechanical ventilation in difficult to wean patients is best accomplished by intermittent spontaneous breathing trials (1). Optimal respiratory muscle rest in-between breathing trials however has never been investigated. Using a crossover design, patients are to be ventilated with complete and partial respiratory muscle unloading for a period of ten hours respectively. Respiratory muscle activity is being monitored by oesophageal balloon technique using a commercially available System (Avea, Viasys, Conshohocken, PA, USA). Time of spontaneous breathing, respiratory- and ABG parameters are being determined to characterize the course of each spontaneous breathing trial. References 1\. Esteban, A., F. Frutos, M. J. Tobin, I. Alia, J. F. Solsona, I. Valverdu, R. Fernandez, M. A. de la Cal, S. Benito, R. Tomas, and et al. 1995. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med 332(6):345-50.

Interventions

Sponsors

Krankenhaus Kloster Grafschaft
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* hypercapnic respiratory failure

Exclusion criteria

* upper Gi pathology * renal failure (creatinin \> 2 mg/dl) * Sepsis or infection * age \< 18 years

Design outcomes

Primary

MeasureTime frame
Endurance time

Secondary

MeasureTime frame
PCO2, respiratory parameters

Countries

Germany

Contacts

Primary ContactDominic Dellweg, M.D.
d.dellweg@fkkg.de+49 2972 791
Backup ContactDieter Koehler, M.D. Prof.
d.koehler@fkkg.de+40 2972 791

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026